Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “Summit Corporation Plc”

6 pharma patents match "Summit Corporation Plc" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 6
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 6 pharmaceutical patents matching "Summit Corporation Plc" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

6 results for “Summit Corporation Plc” · 30,257 patents in full index Clear search

  1. US 9492433

    Pharmaceutical composition for the treatment of Duchenne muscular dystrophy

    Summit Corporation Plc · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  2. US 8987308

    Compounds for the treatment of Clostridium difficile-associated disease

    Summit Corporation Plc · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  3. US 8975416

    Antibacterial compounds

    Summit Corporation Plc · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted

  4. US 8518980

    Treatment of Duchenne muscular dystrophy

    Summit Corporation Plc · Granted Aug 27, 2013 · Expires Aug 22, 2033

    granted

  5. US 8501713

    Drug combinations for the treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted

  6. US 8138351

    Treatment of duchenne muscular dystrophy

    Summit Corporation Plc · Granted Mar 20, 2012 · Expires Mar 15, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.